Sichuan University

NCT07374250

Phase 2, Not yet recruiting, 2026, 154 people, 28 Jan 2026, clinicaltrials.gov

NCT07258147

Phase 2, Not yet recruiting, 2026, 30 people, 2 Dec 2025, clinicaltrials.gov

NCT07004244

Phase 1, Recruiting, 2025, 20 people, 4 Jun 2025, clinicaltrials.gov

NCT06877299

Phase 2, Recruiting, 2025, 30 people, 14 Mar 2025, clinicaltrials.gov

NCT06769971

Phase 2, Recruiting, 2025, 80 people, 10 Jan 2025, clinicaltrials.gov

NCT06769295

Phase 2, Recruiting, 2025, 28 people, 10 Jan 2025, clinicaltrials.gov

NCT06732258

Phase 1, Withdrawn, 2025, 0 people, 13 Dec 2024, clinicaltrials.gov

NCT06477523

Phase 1/2, Active, not recruiting, 2024, 57 people, 27 Jun 2024, clinicaltrials.gov

NCT06403878

Phase 2, Status unknown, 2024, 68 people, 8 May 2024, clinicaltrials.gov

NCT06217757

Phase 1/2, Recruiting, 2024, 45 people, 22 Jan 2024, clinicaltrials.gov

NCT06075225

Phase 2, Status unknown, 2023, 62 people, 10 Oct 2023, clinicaltrials.gov

NCT05948449

Phase 2, Status unknown, 2023, 37 people, 17 Jul 2023, clinicaltrials.gov

NCT05900921

Phase 2, Status unknown, 2023, 132 people, 13 Jun 2023, clinicaltrials.gov

NCT05765825

Phase 2, Active, not recruiting, 2023, 61 people, 13 Mar 2023, clinicaltrials.gov

NCT05466318

Phase 3, Status unknown, 2022, 306 people, 20 Jul 2022, clinicaltrials.gov

NCT05250362

Phase 1/2, Status unknown, 2022, 56 people, 22 Feb 2022, clinicaltrials.gov

NCT04263870

Phase 2, Status unknown, 2020, 36 people, 11 Feb 2020, clinicaltrials.gov

NCT04069949

Phase 1/2, Status unknown, 2019, 39 people, 28 Aug 2019, clinicaltrials.gov

NCT04012619

Phase 1, Completed, 2019, 8 people, 9 Jul 2019, clinicaltrials.gov

NCT03613428

Phase 1/2, Status unknown, 2018, 12 people, 3 Aug 2018, clinicaltrials.gov

Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study

4 Oct 2026, api.crossref.org

Conventional and Shared Genetic Association Analysis Between Diabetes Mellitus and Sensorineural Hearing Loss

2023HXBH119, ZYJC21027, 15 Sept 2026, api.crossref.org

SIRT1 promotes endothelial activity and osteogenesis in vitro and ameliorates age-related skeletal regeneration defects in vivo

RD-02-202506, 3 Sept 2026, api.crossref.org